Loading…

3.0T 31P MR spectroscopy in assessment of response to antiviral therapy for chronic hepatitis C

AIM:To investigate the utility of phosphorus-31(31P)magnetic resonance spectroscopy(MRS)as a noninvasive test for assessment of response to interferon and ribavirin treatment in patients with different severities of hepatitis C virus infection.METHODS:Sixty chronic hepatitis C patients undergoing an...

Full description

Saved in:
Bibliographic Details
Published in:World journal of gastroenterology : WJG 2014-02, Vol.20 (8), p.2107-2112
Main Authors: Zhang, Chun-Yu, Zhang, Qian, Zhang, Hui-Mao, Yang, Hai-Shan
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:AIM:To investigate the utility of phosphorus-31(31P)magnetic resonance spectroscopy(MRS)as a noninvasive test for assessment of response to interferon and ribavirin treatment in patients with different severities of hepatitis C virus infection.METHODS:Sixty chronic hepatitis C patients undergoing antiviral therapy with interferon and ribavirin underwent 31P MRS at 3.0T before treatment,6 mo after the start of treatment,and 1 year after the start of treatment.RESULTS:The phosphomonoester(PME)/phosphodiester(PDE)ratio at 6 mo after the start of antiviral therapy in the Child-Pugh B and C groups were significantly higher than those before therapy,but this was not seen in the Child-Pugh A group.In the antiviral therapy group,the PME/PDE ratios had decreased on follow-up MR spectroscopy.However,in the virological nonresponder group,the PME/PDE ratios on follow-up imaging were similar to the baseline values.CONCLUSION:31P MRS can be used to provide biochemical information on hepatic metabolic processes.This study indicates that the PME/PDE ratio can be used as an indicator of response to antiviral treatment in chronic hepatitis C patients.
ISSN:1007-9327
2219-2840
DOI:10.3748/wjg.v20.i8.2107